Cat Vaccines Market Size, Share, Growth – By Vaccine Type, By Disease Type, By Route of Administration, By Component, By Duration of Immunity – Global Forecast, 2025 – 2034

Cat Vaccines Market Size

The cat vaccines market size was valued at USD 1.1 billion in 2024 and is estimated to grow at a CAGR of 9.2% from 2025 to 2034. This market is growing at a rapid rate owing to the pet owners rising healthcare awareness relative to the population and their increasing pets globally. Vaccination is important for pet cats as it helps in preventing them from several diseases, which include feline leukemia, feline panleukopenia, feline respiratory diseases, and rabies that are common among domestic and stray cats. With the rise in healthcare precaution awareness among pet owners, the demand for vaccines has risen significantly.
 

Furthermore, there has been a greater emphasis on zoonotic diseases, which has resulted in increased necessary precautionary measures when it comes to vaccination for diseases like rabies, motivating factors for increased focus towards zoonotic disease precautionary measures like vaccination. All these factors are together increasing utilization of veterinary vaccines as well as cat vaccines in particular, which results in increased market demand. In addition, the increased usage penetration of pampering insurance and pet care services is supporting the market growth.
 

Cat vaccines are a type of animal vaccine made to protect pet animals, particularly cats, from different infectious diseases. These vaccines encompass those for feline leukemia and feline respiratory diseases, together with lesser-known ones like rabies. Cat vaccines assist in preventing these diseases by stimulating the immune systems of both indoor and outdoor cats.
 

Cat Vaccines Market Trends

Increasing pet ownership and rising expenditures on pet health are key trends driving the growth of the market.
 

• The British Pet Owners survey in 2023 indicated that out of the whole adult population, around 24%, which includes 11 million adults, owned pet cats. With increasing inclusion of cats as family members, their investment in preventative healthcare increases.
   
• This includes routine cat vaccinations and Feline Leukemia testing and Rabies testing, especially since 90% of cats in the UK are allowed outdoors, increasing their risk of exposure to pathogens.
   
• In addition, as required by the Humane Society of Huron Valley, spending for cat's health is on the up and up, since owners are usually shelling out between USD 65 – USD 150 on vaccines and check-ups annually, and up to an additional USD 350 for outdoor cats that need more extensive care which includes heartworm and flea/tick preventatives, more vaccinations, etc.
   
• However, spending these amounts shows that there is, in fact, a growing understanding of the health requirements of pets and a greater readiness to spend on taking preventative measures. Thus, the supply of vaccine options is clearly not enough to meet the steady increase in demand, leading to growth in the market.
   

Cat Vaccines Market Analysis

Based on vaccine type, the global market is segmented into modified/attenuated live, inactivated, and other vaccine types. The modified/attenuated live segment accounted for highest market share of 50.5% in 2024.
 

• The growth of the segment is primarily due to the type's potent efficacy coupled with strong immune response mounted at a relatively low cost, which makes it popular among veterinarians and pet owners.
   
• In addition, these vaccines confer strong and durable immunity to highly prevalent and severe feline diseases such as feline leukemia, feline panleukopenia and feline respiratory diseases, which propels its adoption.
   
• Furthermore, these vaccines help rapidly build immunity, which is especially important in high-risk environments such as shelters where disease could easily spread, thus helping the increasing need for active and simple preventive care in cats.
   

Based on disease type, the cat vaccines market is categorized into feline leukemia, feline panleukopenia (feline distemper), feline respiratory diseases, feline rabies, and other disease types. The feline respiratory diseases segment dominated the market and was valued at USD 363.7 million in 2024.
 

• Feline respiratory diseases comprising Feline Herpesvirus (FHV) and Feline Calicivirus (FCV) infections are some of the most common and infectious diseases of cats, spread more so in cat rushes like catteries and animal shelters.
   
• The demand for preventative vaccines has increased tremendously since these diseases pose chronic complications and harsh symptoms like difficulty in speaking, breathing, and loss of appetite.
   
• Furthermore, veterinarians are recommending the vaccine for cats, which has also increased the demand, especially for indoor and outdoor cats.
   
• These high frequencies of the respiratory disease, their severe consequences, and the shift to prevention has given focus to the market, which main value proposition is on paying for premium clinical care.
   

Based on route of administration, the cat vaccines market is divided into injectables and intranasal. The injectables segment held the highest market share and is expected to grow at 9% CAGR over the analysis period.
 

• The increased marketing and ease of use for on-the-shelf products paired with the overarching health movement have aided in the single largest growth in this area, correlated to the long-lasting immunities provided by injectable vaccines aiding people's busy lives.
   
• Rather, in most modern clinical settings, single doses are also more cost-effective for administering vaccines, which has simplified injectables and made it routine in feline healthcare.
   
• Additionally, these vaccines provide long-ranging immunity while being extremely easy to use in single-dose settings, which are desired for more pets, especially for working parents.
   
• This imbalance in the market has enabled injectables to become the most flexible and thus popular option for feline vaccines, allowing them to cover the whole market.
   

Based on component, the global cat vaccines market is classified into combined vaccine and mono vaccine. The combined vaccine dominated the market with USD 643.1 million revenue in 2024.
 

• Combined vaccine enables owners to protect their pets from more than one disease such as Feline Viral Rhinotracheitis, Calicivirus and Panleukopenia with one vaccination. It has proven beneficial for comprehensive feline immunization as it lessens the amount of pet visits to the vet needed, thus making pets more compliant to vaccines.
   
• Furthermore, mixed vaccines save pets from undergoing multiple injections, making it less stressful for the pet and cheaper for the owner.
   
• The sustained adoption of combined vaccines has resulted in major shares of the segment and hence, accelerated growth of the market.
   

Based on the duration of immunity, the cat vaccines market is segmented into 1 year, 3 years and other durations of immunity. The 1 year segment is expected to reach USD 1.3 billion in 2034.
 

• The 1-year immunity vaccine is widely accepted in veterinary practice. Its endorsement stems from its historical effectiveness, making it a trusted choice among veterinarians and pet owners.
   
• The duration of immunity for 1 year fits the core vaccination protocols provided by veterinarians and relevant authorities, and this has further increased the demand for 1-year vaccines.
   

• In addition, these vaccines protect against common feline diseases, including feline leukemia and panleukopenia, accurately and reliably.
   

The U.S. held a significant market share in the North American cat vaccines market and was valued at USD 378.7 million in 2024.
 

• This market's value can be corroborated by the country's massive population of pet owners, alongside a well-equipped veterinary sector that caters to constant demand for vaccinations to shield cats from prevalent infectious diseases.
   
• For example, one piece of evidence entails the recent Worldostats report stating that the U.S. claimed the lead in the pet cat population worldwide, with an astounding 90 million pet cats.
   
• Moreover, the U.S. derives benefits from having a developed veterinary infrastructure that provides easy access to veterinary clinics and pet care services, thereby outreaching the growth in the market.
   

Germany cat vaccines market is anticipated to witness significant growth over the forecast period.
 

• The need for key preventative measures is growing among German cat owners, which will, in turn, foster a culture of routine vaccination as an accepted norm of responsible pet ownership.
   
• In addition, animal health regulations in Germany, such as routine rabies vaccinations in certain areas, have fostered an environment that promotes the use of preventative vaccines.
   

China is expected to experience growth at significant rate during the analysis period.
 

• It is estimated in the World Population Report Review that cat ownership in China is on the rise due to an estimated 53.1 million feline pets domesticated in the country.
   
• Domesticated cats are an integral part of Chinese culture and is believed to symbolize good luck hence they are greatly appreciated as pets. In addition, cats low maintenance, quiet demeanor, coupled with affordability makes them a favorite in many households.
   
• The increase in population of pet cats has contributed to the growing demand of vaccinations for prevention of common feline diseases, therefore increasing the demand for cat vaccines in the country.
   

Brazil cat vaccines market is projected to showcase lucrative growth during the forecast timeframe.
 

• As per the World Population Review, the estimated pet cat population stands at approximately 22.1 million, which drives the market along with the expected profitable growth due to increased use of cat poses.
   
• The growing appreciation of the Brazilian Shorthair breed among pet owners coupled with heightened focus on pet care has increased the need of vaccines to prevent common ailments.
   
• Further developing veterinary service infrastructures and this growing aspect of Brazil's economy is its pet industry, that brings new pet accessibilities, helps in supporting the favorable growth of the market during the projected period.
   

Saudi Arabia cat vaccines market is poised to grow in the coming years.
 

• The newly adopted policies by the Saudi government to improve veterinary services and animal husbandry is helping grow the market together with increasing funding for specialized veterinary clinics and hospitals for pets.
   
• In addition, more sophisticated vaccines coupled with a stronger inclination towards preventive health care such as routine examinations are contributing towards the growth of the market in Saudi Arabia.
   

Cat Vaccines Market Share

The market is highly competitive with leading players such as Merck, Boehringer Ingelheim, Zoetis, Elanco, and other major companies that dominate the industry. This segment is characterized by important market strategies like product portfolio expansion, targeted particularly on novel formulations such as combined vaccines, which provide multi-disease control with a single dose, or those that provide extended duration of immunity. Furthermore, these newly emerging markets are important for expansion as there is increasing awareness of caring for pets.
 

Cat Vaccines Market Companies

Few of the prominent players operating in the cat vaccines industry include:

• Bioveta
• Boehringer Ingelheim
• Durvet
• Elanco
• Indian Immunologicals
• INTAS Animal Health
• Merck
• Spectra
• Virbac
• Zoetis
   

• Zoetis has sustained the efforts of its comprehensive range of vaccines for cats which include core and non-core vaccines with high safety and efficacy levels. Access to their new solutions in feline health is made possible by the strong R&D and the existing global distribution network.
   
• Merck is a leader in the animal health market with its PUREVAX vaccines, which utilize recombinant technology and are effective against most feline diseases. The company’s market leadership is bolstered by eliminating negative side effects and focus on proactive veterinary assistance.
   

Cat Vaccines Industry News

• In September 2024, Merck Animal Health launched the RNA-particle technology vaccine for Feline Leukemia Virus which they incorporated into the existing NOBIVAC NXT platform. This innovation will positively bolster the company’s standing as a leader in the feline vaccine market by providing an answer to the increasing need for effective feline leukemia prevention.
   
• In June 2024, Merck Animal Health has launched NOBIVAC NXT rabies portfolio and added NOBIVAC NXT Feline-3 rabies and NOBIVAC NXT Canine-3 rabies to the family of products. This proves that the company continues working towards rabies protection. The company gains from increasing its product range in Canada and reinforces its leadership position in rabies prevention in cats and dogs.
   

The cat vaccines market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Vaccine Type

• Modified/attenuated live
• Inactivated
• Other vaccine types

Market, By Disease Type

• Feline respiratory diseases
• Feline leukemia
• Feline panleukopenia (feline distemper)
• Feline rabies
• Other disease types

Market, By Route of Administration

• Injectables
• Intranasal

Market, By Component

• Combined vaccine
• Mono vaccine

Market, By Duration of Immunity

• 1 year
• 3 years
• Other durations of immunity

The above information is provided for the following regions and countries:

• North Amrica
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE